High-titer convalescent plasma associated with lower risk for death from COVID-19
3 days ago - By Healio
Among hospitalized patients with COVID-19 who were not on mechanical ventilation, receiving high-titer convalescent plasma was associated with a lower risk for death than receiving plasma with lower antibody levels, researchers reported.
“In response to the coronavirus pandemic, the Mayo Clinic initiated - along with support and direction from the Biomedical Advances Research and Development Authority and the FDA - the U.S. Expanded Access Program for convalescent plasma to provide access to and assess the safety profile of this experimental therapy,” Michael J. Joyner,
Read more ...
Top in hem/onc: Blood type and COVID-19, breast cancer risk factors
3 days ago - By Healio
New research contradicts previous study findings that suggest there is an association between blood type and COVID-19 severity. It was the top story in hematology/oncology last week.
Another top story was about a study that showed certain gene sets and early-life adiposity may be linked to an increased risk for breast cancer.
Read these and more top stories in hematology/oncology below:
Studies contradict earlier findings on blood group and COVID-19 severity, mortality
Previous studies have shown that individuals with blood type A may be more likely to develop COVID-19 and have poor outcomes.
Read more ...
The headlines of Master Doctor
Social Isolation Linked to COVID-19 Protocol Resistance
A new study provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.
Los Angeles: First US Country to Top 1 Million COVID-19 Cases
The Los Angeles County has became the first country in the United States to surpass 1 million coronavirus cases, since the onset of the pandemic, said health officials.
Anti Diabetic Drug Metformin Reduces Mortality In COVID-19 Patients
Patients with diabetes and COVID-19 taking metformin before testing positive were associated with a decrease in mortality risk than those taking other anti-diabetic drugs.
New Drug Combination Discovered To Treat A Rare Cancer Form
A rare form of lymphoma can be effectively treated with a combination of ibrutinib and JQ1 inhibitors that increase the efficacy of ibrutinib.
Major events show CNN complicit in Capitol raid
After infiltrating the Capitol on Jan. 6 while dressed as a “Trump supporter,” far-left extremist John Sullivan was interviewed by CNN‘s Anderson Cooper, who promoted...
COVID-19 Reduces US Life Expectancy
In the United States, the COVID-19 pandemic has significantly affected life expectancy.
CDC Says UK COVID-19 Variant Could be Dominant US Strain By March
UK COVID-19 variant which has spread to several countries across the globe, could become the dominant virus strain in the US by March, said CDC.
COVID-19 Vaccination Drive: 1.65 Lakh Beneficiaries Inoculated on Day 1
On the first day of the vaccination drive at 3,351 session sites across India, as many as 1.65 lakh beneficiaries were inoculated, said the Centre. No case of post-vaccination...
What Evidence Is Aiding School Reopening Decisions?
This story was originally published on July 10, 2020. As part of MedPage Today's review of the past year's top stories, we are republishing it, along with an update on school...
Pfizer's MRNA-Based Covid Vaccine Suspended
Over 23 Norwegian people who received Pfizer's mRNA-based Covid-19 vaccine died due to the vaccines' safety uncertainties. The new mRNA vaccine was developed in haste and had...